BRIEF-EMA Publishes Clinical Data On Use Of A Booster Dose Of Spikevax In Adolescents Aged 12-18

BRIEF-EMA Publishes Clinical Data On Use Of A Booster Dose Of Spikevax In Adolescents Aged 12-18
European Medicines Agency

European Medicines Agency:

* EMA PUBLISHED CLINICAL DATA ON USE OF A BOOSTER DOSE OF SPIKEVAX IN ADOLESCENTS AGED 12 TO 18: 29/08/2022

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.